Ital­ian an­titrust agency in­ves­ti­gates No­var­tis, Bio­gen and oth­ers over Lu­cen­tis biosim­i­lar

Ital­ian an­titrust au­thor­i­ties are in­ves­ti­gat­ing four com­pa­nies over al­leged col­lu­sion to de­lay the in­tro­duc­tion of a new biosim­i­lar to Roche’s block­buster eye drug Lu­cen­tis. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.